Some reports clarified the biological significance of MK2 in cancer progression including in breast cancer, colorectal cancer, and head and neck squamous cell carcinoma; however, the contribution of MK2 in cancer motility remains largely unknown (30, 31, 32, 33, 34). This evidence concerns the gene MAPKAPK2 and breast carcinoma.